Jennison Associates’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-673,932
| Closed | -$27.1M | – | 597 |
|
|
2025
Q1 | $27.1M | Buy |
+673,932
| New | +$27.1M | 0.02% | 295 |
|
|
2022
Q4 | – | Sell |
-14,358
| Closed | -$696K | – | 586 |
|
|
2022
Q3 | $696K | Buy |
+14,358
| New | +$696K | ﹤0.01% | 549 |
|
|
2020
Q4 | – | Sell |
-270,382
| Closed | -$5.85M | – | 652 |
|
|
2020
Q3 | $5.85M | Sell |
270,382
-346,801
| -56% | -$7.51M | ﹤0.01% | 420 |
|
|
2020
Q2 | $14.5M | Buy |
617,183
+3,029
| +0.5% | +$71.4K | 0.01% | 328 |
|
|
2020
Q1 | $7.24M | Buy |
614,154
+4,190
| +0.7% | +$49.4K | 0.01% | 366 |
|
|
2019
Q4 | $6.47M | Buy |
+609,964
| New | +$6.47M | 0.01% | 413 |
|
|
2014
Q2 | – | Sell |
-250,000
| Closed | -$2.38M | – | 711 |
|
|
2014
Q1 | $2.38M | Buy |
+250,000
| New | +$2.38M | ﹤0.01% | 564 |
|